These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17454319)

  • 1. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
    Kobayashi Y; Yasuba H; Kudou M; Kita H
    J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
    Miyagawa T
    Arerugi; 2008 Nov; 57(11):1134-44. PubMed ID: 19052508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids.
    Fujimoto K; Komatsu Y; Yasuo M; Urushihata K; Kubo K
    J Asthma; 2006 Sep; 43(7):501-7. PubMed ID: 16939989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
    J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma].
    Beeh KM; Beier J; Kornmann O; Wiewrodt R; Buhl R;
    Pneumologie; 2002 Feb; 56(2):91-7. PubMed ID: 11842346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
    Vestbo J; Pauwels R; Anderson JA; Jones P; Calverley P;
    Thorax; 2005 Apr; 60(4):301-4. PubMed ID: 15790985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
    You-Ning L; Humphries M; Du X; Wang L; Jiang J
    Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
    Kimura T; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
    Koopmans JG; Lutter R; Jansen HM; van der Zee JS
    Thorax; 2006 Apr; 61(4):306-12. PubMed ID: 16449264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
    Bleecker ER; Nelson HS; Kraft M; Corren J; Meyers DA; Yancey SW; Anderson WH; Emmett AH; Ortega HG
    Am J Respir Crit Care Med; 2010 Apr; 181(7):676-87. PubMed ID: 19910613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
    Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; Pétavy F; James M
    Respir Med; 2006 Jan; 100(1):2-10. PubMed ID: 16243498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A
    Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses.
    Parameswaran K; Fanat A; O'Byrne PM
    Allergy; 2006 Jun; 61(6):731-6. PubMed ID: 16677243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients.
    Mochizuki H; Nanjo Y; Takahashi H
    Geriatr Gerontol Int; 2013 Apr; 13(2):398-404. PubMed ID: 22817699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.
    Masoli M; Weatherall M; Holt S; Beasley R
    Thorax; 2005 Sep; 60(9):730-4. PubMed ID: 16135679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.